Stocks & ETFs Screener: 94 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
950B | 82.8% | 69.2% | 67.9% | 51.8 | 18.7% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Medical Devices |
489B | 75.1% | 60.5% | 61.0% | 19.6 | 19.8% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Respiratory |
283B | 79.8% | 41.5% | 52.1% | 30.1 | 10.7% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
275B | 82.9% | 38.8% | 73.5% | 29.5 | 21.9% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular,Oncology,Immunology,.. |
244B | 92.1% | 59.3% | 94.8% | 17.4 | 11.3% |
| MRK Merck |
Pharmaceuticals
Keytruda, Gardasil, Januvia |
237B | 83.2% | 62.8% | 4.83% | 12.6 | -6.83% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity Medication |
212B | 89.5% | 41.3% | -39.3% | 13.2 | -58.6% |
| PFE Pfizer |
Pharmaceuticals
Vaccines, Antivirals, Oncology |
139B | 58.1% | 67.3% | -36.1% | 14.2 | -8.26% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Oncology, Immunology |
124B | 64.3% | 53.9% | 31.6% | 16.7 | -6.42% |
| SAN Sanofi |
Pharmaceuticals
Immunology, Oncology, Neurology |
122B | 75.4% | 63.1% | -4.95% | 16.5 | -15.3% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Hematology, Immunology |
99.9B | 74.0% | 59.8% | -56.7% | 16.1 | -24.0% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
96.7B | 80.1% | 30.9% | 58.7% | 13.7 | 15.0% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
94.4B | 79.4% | 19.8% | 76.4% | 13.5 | 27.4% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Drugs, Pigments |
56.6B | 56.4% | 37.8% | -60.8% | 16.5 | -27.3% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
52.4B | 88.6% | 68.8% | -51.6% | 19.9 | -35.4% |
| TAK Takeda |
Pharmaceuticals
Gastroenterology, Oncology, Rare |
47.3B | 63.0% | 36.0% | 27.8% | 203 | -3.53% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
30.8B | 48.4% | 1.0% | 4.48% | - | 37.6% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic Drugs, CNS Therapies |
27.8B | 54.1% | 17.8% | 73.7% | 39.7 | 39.6% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Rare Disease, Cancer |
22.7B | 58.0% | 71.4% | 28.3% | 22.2 | 34.1% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
12.3B | 87.5% | 49.7% | 46.5% | 23.9 | 0.31% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
12.1B | 28.9% | 60.3% | -4.82% | - | -25.3% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.6B | 77.8% | 45.2% | 33.8% | 17.6 | -12.9% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.1B | 43.0% | - | 57.0% | 318 | 53.5% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.8B | 51.1% | - | 11.9% | - | 26.5% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
8.19B | 67.4% | - | 87.4% | 89.3 | 19.9% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
7.53B | 32.3% | - | 79.0% | - | 34.4% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.82B | 61.6% | - | 81.3% | - | 31.9% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.52B | 85.5% | 57.2% | 61.3% | 22.8 | -0.61% |
| TARS Tarsus |
Pharmaceuticals
Eyelash Mite Therapy, Ocular |
3.38B | 36.6% | - | 72.0% | - | 32.8% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
2.92B | 64.1% | 0.21% | -23.9% | 14.7 | -38.8% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.62B | 46.8% | - | 40.7% | - | 8.60% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.61B | 29.8% | - | 69.7% | - | 7.02% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
2.53B | 25.8% | - | 93.6% | - | 146% |
| TERN Terns |
Pharmaceuticals
TKI, THR-Agonist, GLP-1-Agonist |
2.35B | 33.7% | - | 61.6% | - | 292% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.27B | 52.5% | 4.23% | -43.3% | 6.30 | -33.9% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.26B | 63.6% | - | 75.9% | - | 69.3% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.10B | 75.5% | 49.4% | -25.9% | 16.9 | -6.22% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
1.96B | 91.9% | - | -40.0% | 10.7 | -11.3% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.84B | 56.8% | 50.1% | -85.5% | 3.70 | -56.6% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.79B | 70.3% | - | 93.4% | 49.8 | 29.2% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Precision Medicine, APOL1 |
1.74B | 24.1% | - | 91.4% | - | 107% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.74B | 48.3% | 73.5% | -78.3% | - | -57.0% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.69B | 61.3% | 34.3% | 82.9% | 24.9 | 58.6% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.9% | 2.39% | 65.4% | 13.4 | -0.32% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, Amx0035, Amx0114 |
1.61B | 30.2% | - | -5.06% | - | 136% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.47B | 26.3% | - | -79.3% | - | -42.8% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.44B | 44.6% | - | 64.8% | - | -13.2% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.43B | 80.5% | - | 77.3% | 27.7 | 33.3% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.37B | 37.1% | - | 92.1% | - | 299% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.32B | 46.1% | - | 41.2% | - | -0.04% |
| RAPP Rapport |
Pharmaceuticals
Antiepileptic, Analgesic |
1.30B | 31.3% | - | 50.5% | - | 13.3% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
1.29B | 33.2% | - | -1.75% | - | -22.8% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Treg Stimulator, PEG-CSF1, TNFR2 |
1.21B | 32.6% | - | 35.4% | - | 232% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.21B | 76.6% | - | -23.9% | 11.5 | -46.6% |
| EYPT Eyepoint |
Pharmaceuticals
Therapeutics, Retinal, Durasert |
1.19B | 27.3% | - | 70.1% | - | 46.0% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
1.18B | 34.4% | - | 8.15% | - | -55.2% |
| TLRY Tilray |
Pharmaceuticals
Cannabis,Beverage,Wellness,Distribu.. |
1.16B | 45.0% | - | -63.0% | - | -47.2% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.13B | 63.0% | - | 86.0% | - | 90.7% |
| PHAT Phathom |
Pharmaceuticals
GERD,Heartburn,H.Pylori,Esophagitis |
1.07B | 65.2% | - | 41.3% | - | 53.4% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.04B | 63.2% | - | -38.2% | 49.3 | 21.4% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Ampreloxetine |
936M | 51.2% | - | 68.7% | 32.4 | 91.2% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
908M | 45.3% | - | -3.94% | 21.6 | 3.44% |
| ARVN Arvinas |
Pharmaceuticals
PROTAC, Cancer, Breast, Prostate |
890M | 39.5% | - | -72.4% | - | -59.0% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
790M | 92.8% | - | 50.7% | 4.54 | -13.3% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
710M | 33.8% | - | -13.1% | - | 225% |
| AQST Aquestive |
Pharmaceuticals
Epinephrine Film, Apomorphine |
686M | 59.2% | - | 71.1% | - | 5.94% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
629M | 40.7% | - | 14.6% | - | -25.6% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
599M | 22.9% | - | 48.6% | - | 148% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
444M | 28.9% | - | -34.2% | - | -54.4% |
| ETON Eton |
Pharmaceuticals
Hormone, Enzyme, Metabolic |
437M | 57.5% | - | 75.0% | - | 3.98% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
420M | 16.2% | - | -83.3% | - | -73.7% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox, TPOXX, Health |
418M | 80.2% | 89.3% | 17.1% | 5.67 | -19.9% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Bipolar Depression, Major |
412M | 43.1% | - | -3.23% | - | 174% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Liquor, Pre-Rolls |
409M | 50.9% | - | -36.1% | - | -20.6% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
382M | 44.5% | - | -64.2% | - | -80.4% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
319M | 30.5% | - | -50.1% | - | -35.3% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release, Formulation |
313M | 45.3% | - | 17.6% | - | 30.1% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
310M | 51.6% | - | -42.3% | 0.64 | -56.0% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Obesity |
284M | 25.5% | - | -49.0% | - | -38.3% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
272M | 31.9% | - | -57.6% | - | -39.4% |
| TVRD Tvardi |
Pharmaceuticals
Oral, STAT3, Inhibitor, Phase-2 |
242M | 28.2% | - | -62.1% | - | -67.2% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading, Payments, Tokenization |
239M | 27.8% | 1.0% | -18.8% | - | -29.5% |
| ACB Aurora Cannabis |
Pharmaceuticals
Dried Cannabis, Cannabis Oil |
238M | 66.3% | - | -37.8% | - | -11.9% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
232M | 35.4% | - | -42.2% | - | -21.0% |
| MDWD Mediwound |
Pharmaceuticals
Eschar,Burn,Therapy,Tissue,Biopharm.. |
219M | 22.6% | - | 28.3% | - | -10.7% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis,Flower,Pre-Rolls,Vapes,Edi.. |
208M | 39.8% | - | -31.8% | 155 | -5.39% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
197M | 24.4% | - | -32.1% | - | 17.8% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
151M | 45.7% | - | 21.4% | - | 60.2% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 33.9% | 0.17% | -58.3% | - | -26.3% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Disease |
132M | 38.9% | - | -6.28% | - | 67.2% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
118M | 67.8% | - | -47.2% | - | -21.3% |
| NTHI NeOnc Technologies |
Pharmaceuticals
Brain, Tumor, Cancer, Drugs |
90.8M | 58.7% | - | -32.1% | - | -38.9% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual, Aspirin, Melatonin |
20.2M | 39.1% | - | -81.5% | - | -99.2% |
| CTXR Citius |
Pharmaceuticals
Immunotherapy, Antibiotic |
19.8M | 35.5% | - | -81.9% | - | -62.2% |